GMRE:NYE-Global Medical REIT Inc (USD)

COMMON STOCK | REIT - Healthcare Facilities |

Last Closing

USD 7.87

Change

+0.07 (+0.90)%

Market Cap

N/A

Volume

0.39M

Analyst Target

USD 14.79
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-24 )

Largest Industry Peers for REIT - Healthcare Facilities

Symbol Name Price(Change) Market Cap
WELL Welltower Inc

+0.97 (+0.77%)

USD 77.61B
VTR Ventas Inc

+0.34 (+0.58%)

USD 24.65B
DOC Healthpeak Properties Inc

+0.21 (+1.04%)

USD 14.07B
CTRE CareTrust REIT Inc.

+0.17 (+0.62%)

USD 5.50B
AHR American Healthcare REIT, Inc.

+0.42 (+1.49%)

USD 4.56B
NHI National Health Investors Inc

+0.32 (+0.46%)

USD 3.17B
LTC LTC Properties Inc

+0.24 (+0.70%)

USD 1.59B
UHT Universal Health Realty Income..

+0.20 (+0.54%)

USD 0.56B
CHCT Community Healthcare Trust Inc

+0.36 (+2.01%)

USD 0.52B
GMRE-PA Global Medical REIT Inc

+0.39 (+1.56%)

USD 0.40B

ETFs Containing GMRE

KBWY Invesco KBW Premium Yield.. 0.00 % 0.35 %

+0.20 (+0%)

USD 0.25B
SDEF 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (REIT - Healthcare Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -29.10% 14% F 8% B-
Dividend Return 7.57% 79% B- 85% B
Total Return -21.53% 14% F 11% F
Trailing 12 Months  
Capital Gain -31.03% 14% F 8% B-
Dividend Return 7.36% 71% C- 83% B
Total Return -23.66% 14% F 10% F
Trailing 5 Years  
Capital Gain -39.83% 38% F 14% F
Dividend Return 31.65% 69% C- 84% B
Total Return -8.18% 31% F 21% F
Average Annual (5 Year Horizon)  
Capital Gain -4.14% 36% F 14% F
Dividend Return 2.50% 36% F 34% F
Total Return 6.64% 86% B+ 91% A-
Risk Return Profile  
Volatility (Standard Deviation) 24.88% 43% F 44% F
Risk Adjusted Return 10.03% 36% F 27% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.